Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia (CROSBI ID 282998)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Jerković, Ivan ; Ljubić, Toni ; Bašić, Željana ; Kružić, Ivana ; Kunac, Nenad ; Bezić, Joško ; Vuko, Arijana ; Markotić, Alemka ; Anđelinović, Šimun SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia // Journal of occupational and environmental medicine, 63 (2021), 1; 32-37. doi: 10.1097/jom.0000000000002020

Podaci o odgovornosti

Jerković, Ivan ; Ljubić, Toni ; Bašić, Željana ; Kružić, Ivana ; Kunac, Nenad ; Bezić, Joško ; Vuko, Arijana ; Markotić, Alemka ; Anđelinović, Šimun

engleski

SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia

Objectives: To examine seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in industry workers population sample. Methods: From 23 to April 28, 2020, we conducted serological testing for antibodies (Immunoglobulin G (IgG) and Immunoglobulin M (IgM)) on 1494 factory employees living in the Split-Dalmatia and Šibenik-Knin County (Croatia). Results: We detected antibodies in 1.27% of participants (95% confidence interval [CI] 0.77-1.98%). In Split facility 13/1316 (0.99%, 95% CI 0.53-1.68%) of participants were tested positive, of which 13/1079 (1.20%, 95% CI 0.64-2.05%) of those living outside the facility and 0/237 (0%, 95% CI 0-1.26%) of those living inside the facility. In Knin facility, 6/178 (3.37%, 95% CI 1.25-7.19%) participants were tested positive for antibodies. Conclusions: The study showed relatively small SARS-CoV-2 antibody seroprevalence in the DIV Group population sample.

COVID-19 ; Croatia ; IgG ; IgM ; SARS-CoV-2 ; seroprevalence

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

63 (1)

2021.

32-37

objavljeno

1076-2752

1536-5948

10.1097/jom.0000000000002020

Povezanost rada

Kliničke medicinske znanosti, Sigurnosne i obrambene znanosti, Temeljne medicinske znanosti

Poveznice
Indeksiranost